Stomach Neoplasms: all 2,914 studies
Page 22 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Apatinib Dose Titration in Advanced or Metastatic Gastric CancerCompletedNCT02764268Not applicable
- CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsTerminatedNCT02757391Phase 1
- Procalcitonin Reveals Early Dehiscence in Gastric Surgery: the PREDIGS StudyStatus unknownNCT02756455
- Robotic, Laparoscopic and Open Gastrectomy Compared on Short and Long Term OutcomesStatus unknownNCT02751086
- A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric CancerStatus unknownNCT02748551Phase 3
- Study of ONO-4538 in Gastric CancerCompletedNCT02746796Phase 2/3
- Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)CompletedNCT02745509Not applicable
- Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFBCompletedNCT02738294Not applicable
- Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.WithdrawnNCT02736552Phase 3
- Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With BleedingStatus unknownNCT02732483Phase 2
- The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESDCompletedNCT02730533Not applicable
- Community-based Neuroendocrine Tumor (NET) Research StudyCompletedNCT02730104
- Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal CancerCompletedNCT02725424Phase 2
- Study Evaluating the Efficacy and Safety With CAR-T for Stomach CancerStatus unknownNCT02725125Not applicable
- Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric CancerTerminatedNCT02720926Phase 1
- A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard TreatmentCompletedNCT02711969Phase 1
- Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes DissectionStatus unknownNCT02711033Phase 2
- The Feasible Research of Infrared Endoscope to Diagnose Early Gastric CancerStatus unknownNCT02710838Not applicable
- E. Coli Nissle in OncologyCompletedNCT02706184Phase 3
- The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.Status unknownNCT02704299Early Phase 1
- Fish Oil Supplementation in Gastrointestinal CancerStatus unknownNCT02699047Not applicable
- Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric CancerStatus unknownNCT02697838Phase 2
- The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for GastricStatus unknownNCT02694081Phase 2
- Tumor Markers Study in Gastric Cancer for Cancer Immunotherapy (ONCO-RD 010 CRT)SuspendedNCT02686424
- The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric NeoplasmCompletedNCT02682446
- Lifestyle Intervention for Prevention of Gastric NeoplasmStatus unknownNCT02679495Not applicable
- Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer TreatmentStatus unknownNCT02674373
- Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric CancerCompletedNCT02672865Phase 1
- An Open Label, Prospective, Multicentre, Non-interventional Study of Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric CancerStatus unknownNCT02668380
- Serological Screening of Gastric Cancer in Wuxi RegionStatus unknownNCT02663427Not applicable
- Irinotecan as 3rd Line Therapy in Gastric CancerStatus unknownNCT02662959Phase 2
- FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)CompletedNCT02661971Phase 2/3
- Usefulness of Near-focus With Narrow-band ImagingCompletedNCT02661945Not applicable
- Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsCompletedNCT02658214Phase 1
- Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyCompletedNCT02650661Not applicable
- Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative OutcomeCompletedNCT02649348Not applicable
- A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.Status unknownNCT02648841Phase 3
- Postoperative Enteral Immunonutrition in Gastric CancerCompletedNCT02647476Phase 3
- Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer PatientsStatus unknownNCT02644148Phase 2
- Omentectomy for Metabolic Syndrome in Gastric Cancer PatientsStatus unknownNCT02641925Not applicable
- Docetaxel-based Chemoradiotherapy Plus Periradiation Chemotherapy Compared With INT 0116 Adjuvant Arm in Gastric CancerStatus unknownNCT02640898Not applicable
- Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.CompletedNCT02638584Phase 4
- Immunotherapy Using Pluripotent Killer-Human Epidermal Growth Factor Receptor-2 (PIK-HER2) Cells for the Treatment of Advanced Gastric Cancer With Liver MetastasisStatus unknownNCT02632201Phase 1/2
- Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer RiskCompletedNCT02624271Not applicable
- Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric CancerStatus unknownNCT02623153Phase 2
- CAR-T Cell Immunotherapy in MUC1 Positive Solid TumorStatus unknownNCT02617134Phase 1/2
- Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsCompletedNCT02611024Phase 1/2
- Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric CancerStatus unknownNCT02610218
- The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational StudyCompletedNCT02604979
- Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.Status unknownNCT02602249Phase 1
- Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)Status unknownNCT02596256Phase 2
- Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal GastrectomyStatus unknownNCT02595086Not applicable
- Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric CancerWithdrawnNCT02594943Not applicable
- Safety and Efficacy of γδ T Cell Against Gastric CancerStatus unknownNCT02585908Phase 1/2
- The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical StudyStatus unknownNCT02583659
- FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ CancerCompletedNCT02581462Phase 2/3
- Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionCompletedNCT02578368Phase 3
- Impact of Adjuvant FOLFOX on Quality of Life and Sensory Neurotoxicity in Patients With Advanced Gastric CancerStatus unknownNCT02577263
- A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.CompletedNCT02576548Phase 1
- Assessment of a Robotic Distal Gastrectomy on Non-inferiority of N2 Area Nodal DissectionCompletedNCT02572050Phase 2
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric CancerCompletedNCT02563054Phase 3
- OLGA Stage is More Appropriate in Predicting Early Gastric CancerCompletedNCT02562976
- Postoperative Analgesic Effect of NefopamCompletedNCT02561494Not applicable
- A Study of Capecitabine (Xeloda) in Combination Chemotherapy Versus Surgery Alone in Participants With Gastric CancerCompletedNCT02560974Phase 3
- Comparison of 7-day PPI-based Standard Triple Therapy and 10-day Bismuth Quadruple Therapy for H. Pylori EradicationCompletedNCT02557932Phase 3
- Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical StudyCompletedNCT02555358Phase 2
- HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal MetastasisStatus unknownNCT02549911Phase 2
- Use of Lidocaine in Endoscopic Submucosal DissectionCompletedNCT02543411Not applicable
- Body Composition After Laparoscopic Gastrectomy for Gastric CancerCompletedNCT02541461Not applicable
- Human Epidermal Growth Factor Receptor 2 (HER2) Advanced Gastric Epidemiology Study in KoreaCompletedNCT02538562
- Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric CancerStatus unknownNCT02537171Phase 3
- Study of Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in Unresectable Gastric CancerStatus unknownNCT02529878Phase 2
- Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric CancerCompletedNCT02528110Phase 2
- Study of Oxaliplatin, Irinotecan, and S-1 in Gastric CancerCompletedNCT02527785Phase 2
- Apatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT02525237Phase 2
- Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric CancerCompletedNCT02521649Phase 2
- Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal ResectionsWithdrawnNCT02519140Phase 3
- Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer PatientsCompletedNCT02518529Phase 2
- A Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 ExpressionTerminatedNCT02512237Phase 1
- Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing SurgeryCompletedNCT02511821Not applicable
- Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT02510469Phase 2/3
- Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric CancerStatus unknownNCT02509806Phase 2/3
- DC-CIK In Combination With Chemotherapy ( Gio / Oxaliplatin or Cisplatin ) Versus First-line Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma Randomized Controlled Phase II Clinical Study of TreatmentStatus unknownNCT02504229Phase 2
- Afatinib, Paclitaxel, 2nd Line, Advanced Gastric CancerCompletedNCT02501603Phase 2
- Phase I Study of Pyrotinib in Patients With HER2-positive Solid TumorsStatus unknownNCT02500199Phase 1
- Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric CancerActive, not recruitingNCT02496273Phase 1
- Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric CancerCompletedNCT02490111Phase 3
- Donafenib Monotherapy for Previously Treated Metastatic Gastric CancerTerminatedNCT02489214Phase 1/2
- Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)TerminatedNCT02488746
- NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric AdenocarcinomaStatus unknownNCT02486601Phase 2
- The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric CancerActive, not recruitingNCT02485015Phase 2
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
- Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric CancerStatus unknownNCT02464215Not applicable
- Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)Status unknownNCT02461407Phase 2/3
- Comparison of the Effects of Continuous Epidural Analgesia and Continuous Intravenous Analgesia on Postoperative Bowel Movement in Patients Undergoing Laparoscopic GastrectomyCompletedNCT02458573Phase 4
- Gastric Cancer Screening Quality Improvement System EstablishmentStatus unknownNCT02457624
- Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal CancerCompletedNCT02454673
- Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer PatientsCompletedNCT02454647
- Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line ChemotherapyCompletedNCT02451956Phase 2